× |
|
Coping With Craving and Withdrawal Due to Substance Use Disorders During the COVID-19 Lockdown PDF |
$40.00 |
|
$40.00 |
× |
      |
The Impact of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) on Prescribing Practices: An Analysis of Data From a Large Midwestern State PDF |
$40.00 |
|
$40.00 |
× |
      |
Moderators and Mediators of Symptoms and Quality of Life Outcomes in an Open-Label Study of Adults Treated for Attention-Deficit/Hyperactivity Disorder PDF |
$40.00 |
|
$40.00 |
× |
      |
A Clinician's Guide to Monitoring Kidney Function in Lithium-Treated Patients PDF |
$40.00 |
|
$40.00 |
× |
      |
Prevalence of Negative Symptoms in Outpatients With Schizophrenia Spectrum Disorders Treated With Antipsychotics in Routine Clinical Practice: Findings From the CLAMORS Study PDF |
$40.00 |
|
$40.00 |
× |
      |
Manic Switch in a Patient With Depression in the Setting of COVID-19 Treatment PDF |
$40.00 |
|
$40.00 |
|